Swiss GastroTalk: Treat-to-Target

Quickfacts

: May 28, 2026
: 18:00–19:00
: Webcast
: English
: Gastroenterology
: CME requested: SGG

The Swiss GastroTalk is a high-level webcast bringing together the two leading experts Prof. Dr. Schreiber and Prof. Dr. Schoepfer for a discussion on the topic “Treat-to-Target”. The discussion will explore the strategy behind the concept, its impact on diagnosis, monitoring, and clinical decision-making, as well as its future direction. This webcast also gives the participants the opportunity to engage with the experts.

Introduction with patient cases

- Case 1 – Crohn’s disease (CD)

- Case 2 – Ulcerative Colitis (UC)

- Why Treat-to-Target? Development of treatment targets in CD, UC

Brief overview of

- Clinical remission vs. biomarker remission vs. endoscopic healing.

Treat-to-Target Concept

- Definition and rationale, treatment targets according to STRIDE II/III (Symptom control, normalisation of CRP/Calprotectin, endoscopic remission, transmural healing).

Diagnosing/Monitoring Strategies

- How do we diagnose? How do we monitor Treat-to-Target? How do we monitor deep remission? (Endoscopy, biomarkers, intestinal ultrasound, MRI enterography)